A Real-World Study in Advanced Non–Small Cell Lung Cancer with KRAS Mutations

BACKGROUND: KRAS gene mutations are well known as a key driver of advanced non–small cell lung cancer (NSCLC). The impact of KRAS-mutant subtypes on the survival benefit from salvage chemotherapy is controversial. Here, we present a real-world study in patients across China with advanced NSCLC with...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Lei, Wang, Wen-xian, Yu, Zong-yang, Liang, Xian-bin, Pan, Wei-wei, Chen, Hua-fei, Wang, Li-ping, Fang, Yong, Wang, Min, Xu, Chun-wei, Fang, Mei-yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2019
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031095/
https://www.ncbi.nlm.nih.gov/pubmed/31881505
http://dx.doi.org/10.1016/j.tranon.2019.12.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031095/
https://www.ncbi.nlm.nih.gov/pubmed/31881505
http://dx.doi.org/10.1016/j.tranon.2019.12.004

Ejemplares similares